These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 12231096)

  • 21. Association of high-density lipoprotein cholesterol with coronary heart disease risk across categories of low-density lipoprotein cholesterol: the atherosclerosis risk in communities study.
    Muntner P; Lee F; Astor BC
    Am J Med Sci; 2011 Mar; 341(3):173-80. PubMed ID: 21042169
    [TBL] [Abstract][Full Text] [Related]  

  • 22. LDL-cholesterol and HDL-cholesterol in ischaemic heart disease.
    Atukorala TM; Gunarathna PH; Ekanayake RA; Wijayawardhana UD
    Ceylon Med J; 1986 Mar; 31(1):9-14. PubMed ID: 3802308
    [No Abstract]   [Full Text] [Related]  

  • 23. Long-term cardiac rehabilitation and exercise training programs improve metabolic parameters in metabolic syndrome patients with and without coronary heart disease.
    Gayda M; Brun C; Juneau M; Levesque S; Nigam A
    Nutr Metab Cardiovasc Dis; 2008 Feb; 18(2):142-51. PubMed ID: 17142023
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Long-term (5-year) changes in HDL cholesterol in cardiac rehabilitation patients. Do sex differences exist?
    Warner JG; Brubaker PH; Zhu Y; Morgan TM; Ribisl PM; Miller HS; Herrington DM
    Circulation; 1995 Aug; 92(4):773-7. PubMed ID: 7641355
    [TBL] [Abstract][Full Text] [Related]  

  • 25. LDL-cholesterol as a determinant of coronary heart disease.
    Hunninghake D
    Clin Ther; 1990; 12(5):370-5; discussion 369. PubMed ID: 2268861
    [TBL] [Abstract][Full Text] [Related]  

  • 26. A secondary prevention lipid clinic reaches low-density lipoprotein cholesterol goals more often than usual cardiology care with coronary heart disease.
    Birtcher KK; Greisinger AJ; Brehm BJ; Wehmanen OA; Furman LM; Salinas CC; Mirzai-Tehrane M; Nayak A; Rashid H; Mortazavi A
    J Clin Lipidol; 2010; 4(1):46-52. PubMed ID: 21122626
    [TBL] [Abstract][Full Text] [Related]  

  • 27. [Relation between lipoprotein cholesterol and hypertension and coronary heart disease].
    Li BS
    Zhonghua Xin Xue Guan Bing Za Zhi; 1985 Sep; 13(4):273-4. PubMed ID: 3836886
    [No Abstract]   [Full Text] [Related]  

  • 28. Sex difference between target levels of cholesterol-related parameters and post-PCI long-term clinical outcomes: From the FU-Registry.
    Matsuoka Y; Ike A; Ogawa M; Gondo K; Shirai K; Sugihara M; Nose D; Nishikawa H; Iwata A; Kawamura A; Mori K; Zhang B; Yasunaga S; Miura SI; Saku K
    J Cardiol; 2018 Mar; 71(3):259-267. PubMed ID: 29129396
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Effects of exercise rehabilitation on cardiovascular risk factors in older patients with peripheral arterial occlusive disease.
    Izquierdo-Porrera AM; Gardner AW; Powell CC; Katzel LI
    J Vasc Surg; 2000 Apr; 31(4):670-7. PubMed ID: 10753274
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Influence of low high-density lipoprotein cholesterol and elevated triglyceride on coronary heart disease events and response to simvastatin therapy in 4S.
    Ballantyne CM; Olsson AG; Cook TJ; Mercuri MF; Pedersen TR; Kjekshus J
    Circulation; 2001 Dec; 104(25):3046-51. PubMed ID: 11748098
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Joint effect of high-density lipoprotein cholesterol and low-density lipoprotein cholesterol on the risk of coronary heart disease.
    Hu G; Cui Y; Jousilahti P; Sundvall J; Girman CJ; Antikainen R; Laatikainen T; Tuomilehto J
    Eur J Prev Cardiol; 2013 Feb; 20(1):89-97. PubMed ID: 22023802
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Modification of the lipid profile in coronary patients undergoing cardiac rehabilitation].
    Brízida L; Mendes M; Adegas A; Seabra-Gomes R
    Rev Port Cardiol; 1996 Dec; 15(12):877-83, 863-4. PubMed ID: 9052963
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Effect of combination therapy with lipid-reducing drugs in patients with coronary heart disease and "normal" cholesterol levels. A randomized, placebo-controlled trial. Harvard Atherosclerosis Reversibility Project (HARP) Study Group.
    Pasternak RC; Brown LE; Stone PH; Silverman DI; Gibson CM; Sacks FM
    Ann Intern Med; 1996 Oct; 125(7):529-40. PubMed ID: 8815751
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Primary Low Level of High-Density Lipoprotein Cholesterol and Risks of Coronary Heart Disease, Cardiovascular Disease, and Death: Results From the Multi-Ethnic Study of Atherosclerosis.
    Ahmed HM; Miller M; Nasir K; McEvoy JW; Herrington D; Blumenthal RS; Blaha MJ
    Am J Epidemiol; 2016 May; 183(10):875-83. PubMed ID: 27189327
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Low- and high-density lipoprotein cholesterol goal attainment in dyslipidemic women: The Lipid Treatment Assessment Project (L-TAP) 2.
    Santos RD; Waters DD; Tarasenko L; Messig M; Jukema JW; Ferrières J; Verdejo J; Chiang CW;
    Am Heart J; 2009 Nov; 158(5):860-6. PubMed ID: 19853709
    [TBL] [Abstract][Full Text] [Related]  

  • 36. [Considerable remaining risk in unchecked LDL lowering. Is the HDL increase the way out?].
    MMW Fortschr Med; 2006 Jun; 148(24):6, 8. PubMed ID: 16856232
    [No Abstract]   [Full Text] [Related]  

  • 37. Sex differences in cardiac rehabilitation.
    O'Farrell P; Murray J; Huston P; LeGrand C; Adamo K
    Can J Cardiol; 2000 Mar; 16(3):319-25. PubMed ID: 10744794
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Effectiveness of interventions to reduce coronary heart disease risk.
    Adedeji OO; Oyakhire GK; Saeed AK; Ghamdi AI
    West Afr J Med; 2011; 30(3):197-201. PubMed ID: 22120486
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The beneficial effects of raising high-density lipoprotein cholesterol depends upon achieved levels of low-density lipoprotein cholesterol during statin therapy: Implications for coronary atheroma progression and cardiovascular events.
    Puri R; Nissen SE; Shao M; Kataoka Y; Uno K; Kapadia SR; Tuzcu EM; Nicholls SJ
    Eur J Prev Cardiol; 2016 Mar; 23(5):474-85. PubMed ID: 25691546
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patient profile: primary prevention.
    Bruckert E
    Int J Clin Pract Suppl; 2002 Jul; (130):4-5. PubMed ID: 12296607
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.